Advertisement
Advertisement

ALNY

ALNY logo

Alnylam Pharmaceuticals, Inc.

303.64
USD
Sponsored
+11.06
+3.78%
Jun 04, 16:00 UTC -4
Closed
exchange

Pre-Market

303.95

+0.31
+0.10%

Alnylam Pharmaceuticals, Inc. Financial Snapshot

Market Cap
40.58B
Beta
0.39
Earnings Per Share (EPS)
1.71
Price-to-Book (P/B) Ratio
53.78
Operating Margin
6.45%
Total Debt/Equity (D/E)
127.70%
P/E Ratio
188.99
Return on Equity (ROE)
69.02%
Current Ratio
2.76%
Free Cash Flow
465.38M

Earnings Chart

Advertisement